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ABSTRACT
Surgical skill and strategy for the correction of tetralogy of Fallot (TOF) have improved and resulted in satisfactory out-
comes. However, prematurity and low birth weight continue to remain risk factors for poor outcomes. We present a case of 
a 2,150 g neonate born with TOF, in whom palliation was achieved with right ventricular outflow tract (RVOT) stenting. Sev-
enty-seven days after the procedure, stenosis of RVOT below the stent was identified. At that time his body weight was 4.9 
kg and total corrective surgery was deemed feasible. Eight months following surgical repair, the patient remained well without 
medical intervention. RVOT stenting may be a viable interim procedure while waiting for a low birth weight neonate born 
with TOF and prostaglandin E1 dependency to reach optimal weight to undergo corrective surgery. (Korean Circ J 2011; 
41:744-746)
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Introduction
Surgical skill and strategy for the correction of tetralogy of 
Fallot (TOF) have been improved and resulted in relatively 
satisfactory outcomes. However, prematurity and low birth 
weight continue to remain risk factors for poor outcomes.
1) 
Consistent and optimal results have not been achieved in neo-
nates who waited to reach adequate body weight for correc-
tive surgery.
2)3) Stenting of the right ventricular outflow track 
(RVOT) has been reported as a palliative procedure in low 
birth weight premature neonates.
4-6)
We herein report a case of successful RVOT stenting in a 
low birth weight neonate born with TOF and prostaglandin 
E1 dependency. We think that this is the 1st Korean report of 
RVOT stenting.
Case
A male neonate with a prenatal diagnosis of TOF associat-
ed with pulmonary atresia was born through vaginal delive-
ry following 36 weeks and 5 days of gestation with 2,150 g 
body weight. Postnatal echocardiogram revealed TOF with 
severely restricted pulmonary flow secondary to infundibu-
lar hypertrophy. The pulmonary valve annulus diameter mea-
sured 3.0 mm. Diameters of branch pulmonary arteries mea-
sured 4.3 mm on the right and 4.2 mm on the left. There was 
a U-shaped patent ductus arteriosus that measured 2.4 mm 
in diameter. Because systemic oxygen saturation frequently 
fell below 60%, prostaglandin E1 could not be discontinued. 
Seven days after birth, cardiac catheterization for RVOT 
stenting was performed under general anesthesia. Cefaman-
dole was administered prophylactically and a single dose of 
heparin was administered immediately following puncture 
of the right femoral vein. Hemodynamic studies and right 
ventriculography were performed in the conventional man-
ner. We introduced a 5-F Multi-Purpose catheter (Cook Inc, 
Bloomington, USA) into the left pulmonary artery using a Sunhee Bang, et al.   745
0.032-inch Terumo wire (Terumo Corporation, Tokyo, Japan), 
which was exchanged for a 0.014 inch guide wire (Balance 
Middleweight, Abbott Vascular, Santa Clara, USA). After re-
moving the 5-F catheter, a 7-F long sheath (SHUTTLE SL 
FLEXOR TUOHY BORST, Cook Inc, Bloomington, IL, USA) 
was introduced into the main pulmonary artery through a 
guide wire. A 5×15 mm stent (Palmaz Genesis amiia
TM, Cor-
dis Corporation, Roden, Netherlands) was placed to extend 
from above the level of the pulmonary valve to the infundibu-
lum. Because the proximal infundibulum was not covered 
by the stent, a 4×15 mm stent (Palmaz Genesis amiia
TM, Cor-
dis Corporation, Roden, Netherlands) was additionally insert-
ed to fully cover the infundibulum (Fig. 1). Neither arrhythmia 
nor conduction disturbance occurred secondary to the pro-
cedure. Total fluoroscopy time was 25 minutes. Oxygen satu-
ration of arterial blood was increased to 92% following stent 
insertion, at which point prostaglandin E1 was deemed safe 
for discontinuation. Six days following stent insertion, the 
patient was discharged with aspirin at 5 mg/kg/d. Seventy-
seven days following stent insertion, the infant developed sig-
nificant cyanosis. His percutaneous oxygen saturation dropp-
ed to 68% during irritable state. Echocardiography measured 
peak velocity at 4.3 m/s in the RVOT and stenosis of the RV-
OT below the stent was suspected. The diameter of the main 
pulmonary artery measured 5.0 mm and the diameters of the 
branch pulmonary arteries measured 5.3 mm on the right, 
and 6.4 mm on the left. At this time his body weight was 4.9 
kg and total corrective surgery was deemed appropriate. In-
traoperatively, stenosis of the RVOT below the stent was 
confirmed. The ventricular septal defect was closed with a 
Dacron patch and RVOT widening was performed by in-
fundibulectomy and transannular autologous pericardial pat-
ch insertion following stent removal. The infant was discharg-
ed 25 days after surgery. Eight months following corrective 
operation he remained well without medical intervention.
Discussion
After the initial echocardiographic examination of this pa-
tient, we did not consider waiting for his body weight to be op-
timal for the procedure. Also, we discontinued infusion of 
prostaglandin E1, because it has been associated with higher 
mortality and morbidity.
2)3) Early neonatal correction of TOF 
has been supported by some clinicians.
7) According to the 
‘early repair’ strategy, cardiopulmonary bypass can be per-
formed in infants weighing as little as 2 kg.
7) Therefore, our 
patient might have been a candidate for ‘early repair’. Howev-
er, this strategy remains controversial
7)8) and is not preferred 
at our institution.
Palliative methods for TOF include systemic to pulmonary 
arterial shunt insertion, particularly the modified Blalock-
Taussig shunt, stenting of ductus arteriosus, balloon pulmo-
nary valvuloplasty and RVOT stenting. Pulmonary artery hy-
poplasia and distortion are common complications follow-
ing initial palliation by modified Blalock-Taussig shunt,
9) 
particularly when palliation was performed during the neo-
natal period.
10) According to Gladman et al.
10) neonatal palliat-
ion by modified Blalock-Taussig shunt was associated with 
moderate to severe distortion of the right pulmonary artery 
in 35% of patients, and the need for pulmonary artery inter-
vention in 60% of patients. Therefore, we excluded the mod-
ified Blalock-Taussig shunt as initial palliation. In addition, 
because the ductus arteriosus of our patient was ‘U’ shaped, 
we excluded its stenting as an option, and severe infundibu-
lar hypertrophy excluded isolated balloon pulmonary valvu-
loplasty
11) as a selective palliative method. We ultimately de-
cided to insert a RVOT stent. He was discharged following the 
procedure, and gained adequate body weight for corrective 
repair of TOF. 
Dohlen et al.
4) reported that utilization of low profile, flexi-
ble pre-mounted coronary stent had greatly simplified their 
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Fig. 1. A: pulmonary angiogram showing insertion of 1st stent into the pulmonary value to the infundibulum via main pulmonary artery. B: 
but the proximal infundibulum was not covered by stent. Another stent additionally inserted for full covering of infundibulum. C: pulmonary 
angiogram showing insertion of two stents.746   RVOT Stent in a Neonate With TOF
practice of RVOT stenting. We decided not to use it, because 
medical insurance does not cover use of coronary stent for 
stenting non-coronary vessels in the Republic of Korea. The 
optimal diameter of RVOT stent suggested by Dohlen et al.
4) 
is 1-2 mm larger than the infundibular diameter during di-
astole, and the minimal size of stents used in their study was 
4 mm. The length of the stent should be enough to cover the 
entire stenotic RVOT, and careful attention is needed in the 
positioning. 
Two challenges arose in our case. First, two stents were in-
serted to cover the infundibulum. Second, we were only able 
to defer performing corrective surgery by 3 months. The 3 
months gained appeared to be sufficient to overcome com-
plications associated with repair during early infancy,
12) but 
was a relatively short period to perform ‘right ventricular in-
fundibulum sparing’ strategy.
8) In conclusion, the potential of   
growth of proximal infundibulum should be taken into ac-
count when considering stent positioning.
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